Ventas, Inc. - Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The reporting period ends on March 31, 2026. The filing discloses equity holdings managed by the reporting person (Ventas, Inc.) as of the period end.
Key Financial Metrics and Holdings
The filing text does not provide Ventas, Inc.'s own revenue, profit, cash flow, margins, debt, or liquidity metrics. Instead, it discloses a specific equity position held by the company:
| Issuer | Security Class | Shares Held | Value (USD) | Voting Authority |
|---|---|---|---|---|
| Ardent Health, Inc. | Common Stock (COM) | 9,342,501 | $79,971,809 | Sole |
Note: The filing lists a total of 9,342,501 shares with sole voting authority. No shared or none voting authority is reported for this position.
Material Changes
The filing text does not provide comparative data from the prior period; therefore, material changes in holdings or value cannot be determined from this document alone.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. It is a statutory disclosure of holdings only.
Investor Verification Checklist
- Verify the total value of the Ardent Health, Inc. position ($79,971,809) against current market prices to assess valuation accuracy.
- Confirm whether this position represents a new acquisition, a sale, or a hold from the previous quarter by comparing with prior 13F filings.
- Review Ventas, Inc.'s separate financial reports (e.g., 10-Q or 10-K) for the company's own operational performance, as this filing does not contain that data.